Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT00876993
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2009-04-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Sponsor:
Johns Hopkins All Children's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-06
First Submit QC Date:
None
Study First Post Date:
2009-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-27
Results First Submit QC Date:
None
Results First Post Date:
2019-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-28
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL